An iPSC-derived bio-inspired scaffold modelling the structure and the effects of extracellular matrix in cardiac fibrosis

Francesco Niro,Soraia Fernandes,Marco Cassani,Monica Apostolico,Jorge Oliver-De La Cruz,Daniel Pereira- Sousa,Stefania Pagliari,Vladimir Vinarsky,Zbyněk Zdráhal,David Potesil,Vaclav Pustka,Giulio Pompilio,Elena Sommariva,Davide Rovina,Angela Serena Maione,Luca Bersanini,Malin Becker,Marco Rasponi,Giancarlo Forte

DOI: https://doi.org/10.1101/2024.02.07.578948

2024-02-08

Abstract:Cardiac fibrosis occurs following insults to the myocardium and is characterized by the abnormal accumulation of non-compliant extracellular matrix (ECM), which compromises cardiomyocyte contractile activity and eventually leads to heart failure. This phenomenon is driven by the differentiation of cardiac fibroblasts (cFbs) into myofibroblasts and results in changes in ECM biochemical, structural and mechanical properties. The lack of predictive models of heart fibrosis has so far hampered the search for innovative treatments. Here, we devised a single-step decellularization protocol to obtain and thoroughly characterize the biochemical and micro-mechanical properties of the ECM secreted by activated cFbs differentiated from human induced pluripotent stem cells (iPSCs). We activated iPSC-derived cFbs to the myofibroblast phenotype by tuning basic fibroblast growth factor (bFGF) and transforming growth factor beta 1 (TGF-β1) signalling and confirmed that activated cells acquired key features of myofibroblast phenotype, like SMAD2/3 nuclear shuttling, the formation of aligned alpha-smooth muscle actin (α−SMA)-rich stress fibres and increased focal adhesions (FAs) assembly. Next, we used Mass Spectrometry, nanoindentation, scanning electron and confocal microscopy to unveil the characteristic composition and the visco-elastic properties of the abundant, collagen-rich ECM deposited by cardiac myofibroblasts . Finally, we demonstrated that the fibrotic ECM activates mechanosensitive pathways in iPSC-derived cardiomyocytes, impacting on their shape, sarcomere alignment, phenotype, and calcium handling properties. We thus propose human bio-inspired decellularized matrices as animal-free, isogenic cardiomyocyte culture substrates recapitulating key pathophysiological changes occurring at the cellular level during cardiac fibrosis.

Cell Biology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is the key challenges in the modeling and treatment research of cardiac fibrosis. Cardiac fibrosis is a pathological state, usually occurring after myocardial injury, and is characterized by the abnormal accumulation of non - compliant extracellular matrix (ECM), which impairs the contractile function of cardiomyocytes and ultimately leads to heart failure. This process is driven by the differentiation of cardiac fibroblasts (cFbs) into myofibroblasts, resulting in changes in the biochemical, structural and mechanical properties of ECM. Currently, there is a lack of in - vitro models that can accurately predict cardiac fibrosis, which limits the exploration of innovative treatment methods. To overcome this challenge, the research team developed a single - step decellularization protocol to obtain and thoroughly characterize the biochemical and micromechanical properties of ECM secreted by activated cardiac fibroblasts. These cardiac fibroblasts are derived from human induced pluripotent stem cells (iPSCs). By regulating the basic fibroblast growth factor (bFGF) and transforming growth factor β1 (TGF - β1) signaling pathways, the researchers activated iPSC - derived cFbs to the myofibroblast phenotype. The main objectives of the study are: 1. **Develop a new in - vitro model of cardiac fibrosis**: Use the decellularized matrix (dECM) generated by iPSC - derived cardiac fibroblasts, which can simulate the changes in ECM during the cardiac fibrosis process. 2. **Evaluate the impact of fibrotic dECM on iPSC - derived cardiomyocytes**: Study how fibrotic ECM affects the morphology, sarcomere arrangement, phenotype and calcium handling characteristics of cardiomyocytes. 3. **Propose an animal - free, homologous cardiomyocyte culture matrix**: This matrix can reproduce the key pathophysiological changes that occur at the cellular level during cardiac fibrosis. Through these studies, the authors hope to provide a more accurate and effective model system for the mechanism research of cardiac fibrosis and the development of new therapies.

An iPSC-derived bio-inspired scaffold modelling the structure and the effects of extracellular matrix in cardiac fibrosis

Fibrotic extracellular matrix impacts cardiomyocyte phenotype and function in an iPSC-derived isogenic model of cardiac fibrosis

Biomimetic Electrospun Scaffold-Based In Vitro Model Resembling the Hallmarks of Human Myocardial Fibrotic Tissue

Investigations of cardiac fibrosis rheology by in vitro cardiac tissue modeling with 3D cellular spheroids

Cardiac-derived extracellular matrix: A decellularization protocol for heart regeneration

New recellularizable cardio-matrix scaffold as a base for alternative in vitro models for the cardiotoxicity risk prediction

3D bioartificial stretchable scaffolds mimicking the mechanical hallmarks of human cardiac fibrotic tissue

Matrix Architecture and Mechanics Regulate Myofibril Organization, Costamere Assembly, and Contractility in Engineered Myocardial Microtissues

Mechanical stimulation of induced pluripotent stem derived cardiac fibroblasts

Extracellular matrix remodeling and cardiac fibrosis

Acellular bioscaffolds redirect cardiac fibroblasts and promote functional tissue repair in rodents and humans with myocardial injury

Cell-derived Extracellular Matrix-Coated Silk Fibroin Scaffold for Cardiogenesis of Brown Adipose Stem Cells Through Modulation of TGF-β Pathway.

Primary Human Cell-Derived Extracellular Matrix from Decellularized Fibroblast Microtissues with Tissue-Dependent Composition and Microstructure

Substrate Stiffness Influences Structural and Functional Remodeling in Induced Pluripotent Stem Cell-Derived Cardiomyocytes

Experimental Models to Study Endothelial to Mesenchymal Transition in Myocardial Fibrosis and Cardiovascular Diseases

Molecular and metabolomic characterization of hiPSC-derived cardiac fibroblasts transitioning to myofibroblasts

Cellular Alignment and Matrix Stiffening Induced Changes in Human Induced Pluripotent Stem Cell Derived Cardiomyocytes

Microengineered in Vitro Model of Cardiac Fibrosis Through Modulating Myofibroblast Mechanotransduction.

Scaffolds Functionalized with Matrix from Induced Pluripotent Stem Cell Fibroblasts for Diabetic Wound Healing

Paracrine Effects of Adipose-Derived Stem Cells on Matrix Stiffness-Induced Cardiac Myofibroblast Differentiation Via Angiotensin II Type 1 Receptor and Smad7.

Generation of a human iPSC-derived cardiomyocyte/fibroblast engineered heart tissue model